|
Liver Cirrhosis, Experimental
|
0.500 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
|
21088392 |
2011 |
|
Liver Cirrhosis, Experimental
|
0.500 |
Biomarker
|
disease |
RGD |
Fraxinus rhynchophylla ethanol extract attenuates carbon tetrachloride-induced liver fibrosis in rats via down-regulating the expressions of uPA, MMP-2, MMP-9 and TIMP-1.
|
20035854 |
2010 |
|
Infarction, Middle Cerebral Artery
|
0.500 |
Therapeutic
|
disease |
CTD_human |
Neurological picture. Orolingual angio-oedema after alteplase therapy in a stroke patient concurrently using angiotensin II receptor blocker.
|
20547619 |
2010 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
|
20212195 |
2010 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
|
19095969 |
2009 |
|
Infarction, Middle Cerebral Artery
|
0.500 |
Therapeutic
|
disease |
CTD_human |
[Orolingual angioedema as complication after rt-PA in stroke patient treated with ACE inhibitor].
|
18453163 |
2008 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.
|
18753474 |
2008 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
|
18369171 |
2008 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography.
|
18346647 |
2008 |
|
Infarction, Middle Cerebral Artery
|
0.500 |
Therapeutic
|
disease |
CTD_human |
Assessment of suitability of thrombolysis in middle cerebral artery infarction: a proof of concept study of a stereologically-based technique.
|
17690543 |
2007 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Assessment of suitability of thrombolysis in middle cerebral artery infarction: a proof of concept study of a stereologically-based technique.
|
17690543 |
2007 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Argatroban tPA stroke study: study design and results in the first treated cohort.
|
16908730 |
2006 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
|
16126134 |
2005 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Our findings suggest that endogenous tPA plays an important role in heparin-produced cerebral hemorrhage via MMP9 induction and activation.
|
16190367 |
2005 |
|
Reperfusion Injury
|
0.500 |
Biomarker
|
disease |
RGD |
Reductions in mRNA of the neuroprotective agent, neuroserpin, after cerebral ischemia/reperfusion in diabetic rats.
|
15223382 |
2004 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice.
|
14630814 |
2004 |
|
Infarction, Middle Cerebral Artery
|
0.500 |
Biomarker
|
disease |
RGD |
Temporal profile of tissue plasminogen activator (tPA) and inhibitor expression after transient focal cerebral ischemia.
|
14512838 |
2003 |
|
Infarction, Middle Cerebral Artery
|
0.500 |
Therapeutic
|
disease |
CTD_human |
Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.
|
12297567 |
2002 |
|
Cerebral Hemorrhage
|
0.500 |
Therapeutic
|
phenotype |
RGD |
Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship.
|
12220690 |
2002 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
|
11940547 |
2002 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.
|
11113218 |
2000 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Brain hemorrhages after rt-PA treatment of embolic stroke in spontaneously hypertensive rats.
|
10501537 |
1999 |
|
Reperfusion Injury
|
0.500 |
Therapeutic
|
disease |
CTD_human |
tPA-associated reperfusion after acute stroke demonstrated by SPECT.
|
9472885 |
1998 |
|
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.
|
9836764 |
1998 |